Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment

被引：209

作者：

Oeckl, Patrick ^{[1
]}

Halbgebauer, Steffen ^{[1
]}

Anderl-Straub, Sarah ^{[1
]}

Steinacker, Petra ^{[1
]}

Huss, Andre M. ^{[1
]}

Neugebauer, Hermann ^{[1
]}

von Arnim, Christine A. F. ^{[1
]}

Diehl-Schmid, Janine ^{[2
]}

Grimmer, Timo ^{[2
]}

Kornhuber, Johannes ^{[3
,4
]}

Lewczuk, Piotr ^{[3
,4
,5
]}

Danek, Adrian ^{[6
]}

Ludolph, Albert C. ^{[1
]}

Otto, Markus ^{[1
]}

机构：

[1] Ulm Univ Hosp, Dept Neurol, Oberer Eselsberg 45, D-89081 Ulm, Germany

[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, Klinikum Rechts Isar, Munich, Germany

[3] Univ Klinikum Erlangen, Dept Psychiat & Psychotherapy, Erlangen, Germany

[4] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany

[5] Med Univ Bialystok, Dept Neurodegenerat Diagnost, Bialystok, Poland

[6] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany

[7] Univ Ulm, German Consortium Frontotemporal Lobar Degenerat, Ulm, Germany

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2019年 / 67卷 / 02期

关键词：

Alzheimer's disease; astrocyte; biomarker; cerebrospinal fluid; differential diagnosis; frontotemporal dementia; GFAP; Lewy body dementia; Parkinson's disease; serum; NEUROFILAMENT LIGHT-CHAIN; CEREBROSPINAL-FLUID; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; PLASMA; DEMENTIA; RECOMMENDATIONS; CRITERIA; LEVEL;

D O I：

10.3233/JAD-180325

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Reliable blood biomarkers for Alzheimer's disease (AD) are missing. We measured astroglial GFAP in patients with AD (n = 28), frontotemporal dementia (bvFTD, n = 35), Parkinson's disease (n = 11), Lewy body dementias (n = 19), and controls (n = 34). Serum GFAP was increased in AD (p < 0.001) and DLB/PDD (p < 0.01), and cerebrospinal fluid GFAP was increased in all neurodegenerative diseases (p < 0.001). Serum GFAP correlated with the Mini-Mental State Examination score (r = -0.42, p < 0.001) and might be a follow-up marker in clinical trials. Sensitivity and specificity of serum GFAP for AD versus bvFTD was 89% and 79% and might be the first blood biomarker in the differential diagnosis of AD and bvFTD.

引用

页码：481 / 488

页数：8

共 27 条

[1] Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Bacioglu, Mehtap
Maia, Luis F.
Preische, Oliver
Schelle, Juliane
Apel, Anja
Kaeser, Stephan A.
Schweighauser, Manuel
Eninger, Timo
Lambert, Marius
Pilotto, Andrea
Shimshek, Derya R.
Neumann, Ulf
Kahle, Philipp J.
Staufenbiel, Matthias
Neumann, Manuela
Maetzler, Walter
Kuhle, Jens
Jucker, Mathias
[J]. NEURON, 2016, 91 (01) : 56 - 66
[2] Clinical diagnostic criteria for dementia associated with Parkinson's disease
Emre, Murat
Aarsland, Dag
Brown, Richard
Bum, David J.
Duyckaerts, Charles
Mizuno, Yoshikino
Broe, Gerald Anthony
Cummings, Jeffrey
Dickson, Dennis W.
Gauthier, Serge
Goldman, Jennifer
Goetz, Christopher
Korczyn, Amos
Lees, Andrew
Levy, Richard
Litvan, Irene
McKeith, Ian
Olanow, Warren
Poewe, Werner
Quinn, Niall
Sampaio, Christina
Tolosa, Eduardo
Dubois, Bruno
[J]. MOVEMENT DISORDERS, 2007, 22 (12) : 1689 - 1707
[3] The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia
Fukuyama, R
Izumoto, T
Fushiki, S
[J]. EUROPEAN NEUROLOGY, 2001, 46 (01) : 35 - 38
[4] Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role
Garwood, C. J.
Ratcliffe, L. E.
Simpson, J. E.
Heath, P. R.
Ince, P. G.
Wharton, S. B.
[J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2017, 43 (04) : 281 - 298
[5] ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES
HUGHES, AJ
DANIEL, SE
KILFORD, L
LEES, AJ
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) : 181 - 184
[6] Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
Ishiki, Aiko
Kamada, Maki
Kawamura, Yuki
Terao, Chiaki
Shimoda, Fumiko
Tomita, Naoki
Arai, Hiroyuki
Furukawa, Katsutoshi
[J]. JOURNAL OF NEUROCHEMISTRY, 2016, 136 (02) : 258 - 261
[7] Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Jack, Clifford R., Jr.
Albert, Marilyn S.
Knopman, David S.
McKhann, Guy M.
Sperling, Reisa A.
Carrillo, Maria C.
Thies, Bill
Phelps, Creighton H.
[J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 257 - 262
[8] Plasma β-amyloid in Alzheimer's disease and vascular disease
Janelidze, Shorena
Stomrud, Erik
Palmqvist, Sebastian
Zetterberg, Henrik
van Westen, Danielle
Jeromin, Andreas
Song, Linan
Hanlon, David
Tan Hehir, Cristina A.
Baker, David
Blennow, Kaj
Hansson, Oskar
[J]. SCIENTIFIC REPORTS, 2016, 6
[9] Cerebral amyloid angiopathy in Lewy body disease
Jellinger, K. A.
Attems, J.
[J]. JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (03) : 473 - 482
[10] Glial Fibrillary Acidic Protein and Protein S-100B: Different Concentration Pattern of Glial Proteins in Cerebrospinal Fluid of Patients with Alzheimer's Disease and Creutzfeldt-Jakob Disease
Jesse, Sarah
Steinacker, Petra
Cepek, Lukas
von Arnim, Christine A. F.
Tumani, Hayrettin
Lehnert, Stefan
Kretzschmar, Hans A.
Baier, Michael
Otto, Markus
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (03) : 541 - 551

← 1 2 3 →